Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: Implications for disease mechanisms and interventions in synucleinopathies

Stefan Schildknecht, Hanne R. Gerding, Christiaan Karreman, Malte Drescher, Hilal A. Lashuel, Tiago F. Outeiro, Donato A. Di Monte, Marcel Leist

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Alpha-synuclein (ASYN) is a major constituent of the typical protein aggregates observed in several neurodegenerative diseases that are collectively referred to as synucleinopathies. A causal involvement of ASYN in the initiation and progression of neurological diseases is suggested by observations indicating that single-point (e.g., A30P, A53T) or multiplication mutations of the gene encoding for ASYN cause early onset forms of Parkinson's disease (PD). The relative regional specificity of ASYN pathology is still a riddle that cannot be simply explained by its expression pattern. Also, transgenic over-expression of ASYN in mice does not recapitulate the typical dopaminergic neuronal death observed in PD. Thus, additional factors must contribute to ASYN-related toxicity. For instance, synucleinopathies are usually associated with inflammation and elevated levels of oxidative stress in affected brain areas. In turn, these conditions favor oxidative modifications of ASYN. Among these modifications, nitration of tyrosine residues, formation of covalent ASYN dimers, as well as methionine sulfoxidations are prominent examples that are observed in post-mortem PD brain sections. Oxidative modifications can affect ASYN aggregation, as well as its binding to biological membranes. This would affect neurotransmitter recycling, mitochondrial function and dynamics (fission/fusion), ASYN's degradation within a cell and, possibly, the transfer of modified ASYN to adjacent cells. Here, we propose a model on how covalent modifications of ASYN link energy stress, altered proteostasis, and oxidative stress, three major pathogenic processes involved in PD progression. Moreover, we hypothesize that ASYN may act physiologically as a catalytically regenerated scavenger of oxidants in healthy cells, thus performing an important protective role prior to the onset of disease or during aging.

Original languageEnglish
Pages (from-to)491-511
Number of pages21
JournalJournal of Neurochemistry
Volume125
Issue number4
DOIs
Publication statusPublished - 1 May 2013
Externally publishedYes

Fingerprint

alpha-Synuclein
Parkinson Disease
Oxidative stress
Disease Progression
Oxidative Stress
Brain
Mitochondrial Dynamics
Neurodegenerative diseases
Biological membranes
Nitration
Gene encoding
Recycling
Pathology
Oxidants
Neurodegenerative Diseases
Methionine
Neurotransmitter Agents
Tyrosine
Dimers
Toxicity

Keywords

  • aggregation
  • alpha-synuclein
  • dopamine
  • nitric oxide
  • parkinson's disease
  • peroxynitrite

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Oxidative and nitrative alpha-synuclein modifications and proteostatic stress : Implications for disease mechanisms and interventions in synucleinopathies. / Schildknecht, Stefan; Gerding, Hanne R.; Karreman, Christiaan; Drescher, Malte; Lashuel, Hilal A.; Outeiro, Tiago F.; Di Monte, Donato A.; Leist, Marcel.

In: Journal of Neurochemistry, Vol. 125, No. 4, 01.05.2013, p. 491-511.

Research output: Contribution to journalArticle

Schildknecht, S, Gerding, HR, Karreman, C, Drescher, M, Lashuel, HA, Outeiro, TF, Di Monte, DA & Leist, M 2013, 'Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: Implications for disease mechanisms and interventions in synucleinopathies', Journal of Neurochemistry, vol. 125, no. 4, pp. 491-511. https://doi.org/10.1111/jnc.12226
Schildknecht, Stefan ; Gerding, Hanne R. ; Karreman, Christiaan ; Drescher, Malte ; Lashuel, Hilal A. ; Outeiro, Tiago F. ; Di Monte, Donato A. ; Leist, Marcel. / Oxidative and nitrative alpha-synuclein modifications and proteostatic stress : Implications for disease mechanisms and interventions in synucleinopathies. In: Journal of Neurochemistry. 2013 ; Vol. 125, No. 4. pp. 491-511.
@article{16b1bbd306e14e6586086abd684b18cd,
title = "Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: Implications for disease mechanisms and interventions in synucleinopathies",
abstract = "Alpha-synuclein (ASYN) is a major constituent of the typical protein aggregates observed in several neurodegenerative diseases that are collectively referred to as synucleinopathies. A causal involvement of ASYN in the initiation and progression of neurological diseases is suggested by observations indicating that single-point (e.g., A30P, A53T) or multiplication mutations of the gene encoding for ASYN cause early onset forms of Parkinson's disease (PD). The relative regional specificity of ASYN pathology is still a riddle that cannot be simply explained by its expression pattern. Also, transgenic over-expression of ASYN in mice does not recapitulate the typical dopaminergic neuronal death observed in PD. Thus, additional factors must contribute to ASYN-related toxicity. For instance, synucleinopathies are usually associated with inflammation and elevated levels of oxidative stress in affected brain areas. In turn, these conditions favor oxidative modifications of ASYN. Among these modifications, nitration of tyrosine residues, formation of covalent ASYN dimers, as well as methionine sulfoxidations are prominent examples that are observed in post-mortem PD brain sections. Oxidative modifications can affect ASYN aggregation, as well as its binding to biological membranes. This would affect neurotransmitter recycling, mitochondrial function and dynamics (fission/fusion), ASYN's degradation within a cell and, possibly, the transfer of modified ASYN to adjacent cells. Here, we propose a model on how covalent modifications of ASYN link energy stress, altered proteostasis, and oxidative stress, three major pathogenic processes involved in PD progression. Moreover, we hypothesize that ASYN may act physiologically as a catalytically regenerated scavenger of oxidants in healthy cells, thus performing an important protective role prior to the onset of disease or during aging.",
keywords = "aggregation, alpha-synuclein, dopamine, nitric oxide, parkinson's disease, peroxynitrite",
author = "Stefan Schildknecht and Gerding, {Hanne R.} and Christiaan Karreman and Malte Drescher and Lashuel, {Hilal A.} and Outeiro, {Tiago F.} and {Di Monte}, {Donato A.} and Marcel Leist",
year = "2013",
month = "5",
day = "1",
doi = "10.1111/jnc.12226",
language = "English",
volume = "125",
pages = "491--511",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Oxidative and nitrative alpha-synuclein modifications and proteostatic stress

T2 - Implications for disease mechanisms and interventions in synucleinopathies

AU - Schildknecht, Stefan

AU - Gerding, Hanne R.

AU - Karreman, Christiaan

AU - Drescher, Malte

AU - Lashuel, Hilal A.

AU - Outeiro, Tiago F.

AU - Di Monte, Donato A.

AU - Leist, Marcel

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Alpha-synuclein (ASYN) is a major constituent of the typical protein aggregates observed in several neurodegenerative diseases that are collectively referred to as synucleinopathies. A causal involvement of ASYN in the initiation and progression of neurological diseases is suggested by observations indicating that single-point (e.g., A30P, A53T) or multiplication mutations of the gene encoding for ASYN cause early onset forms of Parkinson's disease (PD). The relative regional specificity of ASYN pathology is still a riddle that cannot be simply explained by its expression pattern. Also, transgenic over-expression of ASYN in mice does not recapitulate the typical dopaminergic neuronal death observed in PD. Thus, additional factors must contribute to ASYN-related toxicity. For instance, synucleinopathies are usually associated with inflammation and elevated levels of oxidative stress in affected brain areas. In turn, these conditions favor oxidative modifications of ASYN. Among these modifications, nitration of tyrosine residues, formation of covalent ASYN dimers, as well as methionine sulfoxidations are prominent examples that are observed in post-mortem PD brain sections. Oxidative modifications can affect ASYN aggregation, as well as its binding to biological membranes. This would affect neurotransmitter recycling, mitochondrial function and dynamics (fission/fusion), ASYN's degradation within a cell and, possibly, the transfer of modified ASYN to adjacent cells. Here, we propose a model on how covalent modifications of ASYN link energy stress, altered proteostasis, and oxidative stress, three major pathogenic processes involved in PD progression. Moreover, we hypothesize that ASYN may act physiologically as a catalytically regenerated scavenger of oxidants in healthy cells, thus performing an important protective role prior to the onset of disease or during aging.

AB - Alpha-synuclein (ASYN) is a major constituent of the typical protein aggregates observed in several neurodegenerative diseases that are collectively referred to as synucleinopathies. A causal involvement of ASYN in the initiation and progression of neurological diseases is suggested by observations indicating that single-point (e.g., A30P, A53T) or multiplication mutations of the gene encoding for ASYN cause early onset forms of Parkinson's disease (PD). The relative regional specificity of ASYN pathology is still a riddle that cannot be simply explained by its expression pattern. Also, transgenic over-expression of ASYN in mice does not recapitulate the typical dopaminergic neuronal death observed in PD. Thus, additional factors must contribute to ASYN-related toxicity. For instance, synucleinopathies are usually associated with inflammation and elevated levels of oxidative stress in affected brain areas. In turn, these conditions favor oxidative modifications of ASYN. Among these modifications, nitration of tyrosine residues, formation of covalent ASYN dimers, as well as methionine sulfoxidations are prominent examples that are observed in post-mortem PD brain sections. Oxidative modifications can affect ASYN aggregation, as well as its binding to biological membranes. This would affect neurotransmitter recycling, mitochondrial function and dynamics (fission/fusion), ASYN's degradation within a cell and, possibly, the transfer of modified ASYN to adjacent cells. Here, we propose a model on how covalent modifications of ASYN link energy stress, altered proteostasis, and oxidative stress, three major pathogenic processes involved in PD progression. Moreover, we hypothesize that ASYN may act physiologically as a catalytically regenerated scavenger of oxidants in healthy cells, thus performing an important protective role prior to the onset of disease or during aging.

KW - aggregation

KW - alpha-synuclein

KW - dopamine

KW - nitric oxide

KW - parkinson's disease

KW - peroxynitrite

UR - http://www.scopus.com/inward/record.url?scp=84876790040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876790040&partnerID=8YFLogxK

U2 - 10.1111/jnc.12226

DO - 10.1111/jnc.12226

M3 - Article

C2 - 23452040

AN - SCOPUS:84876790040

VL - 125

SP - 491

EP - 511

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 4

ER -